The international psychiatric sector is witnessing an extraordinary paradigm shift as conventional synthetic pharmaceuticals face intense global scrutiny for their inability to solve long-term cognitive and emotional disorders. In May 2026, researchers, clinical practitioners, and wellness advocates are systematically moving away from short-term chemical symptom-masking and turning toward natural, structural interventions that target the root […]